Spectrophotometric determination of H(2)-receptor antagonists via their oxidation with cerium(IV).
A simple, accurate and sensitive spectrophotometric method has been developed and validated for determination of H(2)-receptor antagonists: cimetidine, famotidine, nizatidine and ranitidine hydrochloride. The method was based on the oxidation of these drugs with cerium(IV) in presence of perchloric acid and subsequent measurement of the excess Ce(IV) by its reaction with p-dimethylaminobenzaldehyde to give a red colored product (lambda(max) at 464nm). The decrease in the absorption intensity of the colored product (DeltaA), due to the presence of the drug was correlated with its concentration in the sample solution. Different variables affecting the reaction were carefully studied and optimized. Under the optimum conditions, linear relationships with good correlation coefficients (0.9990-0.9994) were found between DeltaA values and the concentrations of the drugs in a concentration range of 1-20microgml(-1). The assay limits of detection and quantitation were 0.18-0.60 and 0.54-1.53microgml(-1), respectively. The method was validated, in terms of accuracy, precision, ruggedness and robustness; the results were satisfactory. The proposed method was successfully applied to the determination of the investigated drugs in pure and pharmaceutical dosage forms (recovery was 98.3-102.6+/-0.57-1.90%) without interference from the common excipients. The results obtained by the proposed method were comparable with those obtained by the official methods.
Darwish
Ibrahim A
IA
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt. iadarwish@yahoo.com
Hussein
Samiha A
SA
Mahmoud
Ashraf M
AM
Hassan
Ahmed I
AI
D062365:Aminobenzoates / Q000737:chemistry; D002563:Cerium / Q000378:metabolism*; D002927:Cimetidine / Q000032:analysis / Q000737:chemistry / Q000378:metabolism; D004304:Dosage Forms; D005079:Excipients; D015738:Famotidine / Q000032:analysis / Q000737:chemistry / Q000378:metabolism; D006635:Histamine H2 Antagonists / Q000032:analysis* / Q000737:chemistry / Q000378:metabolism*; D016567:Nizatidine / Q000032:analysis / Q000737:chemistry / Q000378:metabolism; D010084:Oxidation-Reduction; D011899:Ranitidine / Q000032:analysis / Q000737:chemistry / Q000378:metabolism; D015203:Reproducibility of Results; D012997:Solvents; D013053:Spectrophotometry; D013997:Time Factors
D062365:Aminobenzoates; D004304:Dosage Forms; D005079:Excipients; D006635:Histamine H2 Antagonists; D012997:Solvents; D002563:Cerium; D015738:Famotidine; D002927:Cimetidine; D011899:Ranitidine; D016567:Nizatidine